ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,443,000 | -34.3% | 172,370 | -29.8% | 0.02% | -42.3% |
Q1 2017 | $2,195,000 | +1951.4% | 245,563 | +1453.2% | 0.03% | +2500.0% |
Q3 2016 | $107,000 | -71.2% | 15,810 | -84.9% | 0.00% | -75.0% |
Q2 2016 | $372,000 | -17.3% | 104,388 | -2.2% | 0.00% | -20.0% |
Q4 2015 | $450,000 | -53.0% | 106,714 | -60.2% | 0.01% | -66.7% |
Q3 2014 | $958,000 | -43.3% | 268,332 | -27.5% | 0.02% | -42.3% |
Q2 2014 | $1,689,000 | +16.8% | 370,284 | +20.4% | 0.03% | +8.3% |
Q1 2014 | $1,446,000 | +21.9% | 307,577 | +29.9% | 0.02% | +33.3% |
Q4 2013 | $1,186,000 | +400.4% | 236,821 | +522.1% | 0.02% | +260.0% |
Q3 2013 | $237,000 | +144.3% | 38,071 | +78.3% | 0.01% | +150.0% |
Q2 2013 | $97,000 | – | 21,348 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |